Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO

• Autors principals: Lu Bai (Autor), Siwen Sun (Autor), Wenmei Su (Autor), Chaoqun Chen (Autor), Yuesheng Lv (Autor), Jinrui Zhang (Autor), Jinyao Zhao (Autor), Man Li (Autor), Yangfan Qi (Autor), Wenjing Zhang (Autor), Yang Wang (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Hepatocellular carcinoma (HCC) is one of the most common primary cancers with limited therapeutic options. Melatonin, a neuroendocrine hormone produced primarily by the pineal gland, demonstrates an anti-cancer effect on a myriad of cancers including HCC. However, whether melatonin could suppress tu...